Savara, Inc. · NASDAQ:SVRA
Farallon Capital Management, L.L.C. reported a 6.80% stake in Savara, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Farallon Capital Management, L.L.C. reported a 6.80% stake in Savara, Inc., 15,000,000 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 6.80%
- Shares
- 15,000,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 27 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Farallon Capital Management, L.L.C. | 6.80% | 15,000,000 |
| Farallon Capital Partners, L.P. | 0% | 0 |
| Farallon Capital Institutional Partners, L.P. | 0% | 0 |
| Farallon Capital Institutional Partners II, L.P. | 0% | 0 |
| Farallon Capital Institutional Partners III, L.P. | 0% | 0 |
| Four Crossings Institutional Partners V, L.P. | 0% | 0 |
| Farallon Capital Offshore Investors II, L.P. | 0% | 0 |
| Farallon Capital (AM) Investors, L.P. | 0% | 0 |
| Farallon Capital F5 Master I, L.P. | 0% | 0 |
| Farallon Partners, L.L.C. | 0% | 0 |
| Farallon Institutional (GP) V, L.L.C. | 0% | 0 |
| Farallon F5 (GP), L.L.C. | 0% | 0 |
| Dapice Joshua J. | 6.80% | 15,000,000 |
| Dreyfuss, Philip D. | 6.80% | 15,000,000 |
| Dunn Hannah E. | 6.80% | 15,000,000 |
| Gehani, Varun N. | 6.80% | 15,000,000 |
| Giauque, Nicolas | 6.80% | 15,000,000 |
| Husen, Avner A. | 6.80% | 15,000,000 |
| Kim, David T. | 6.80% | 15,000,000 |
| Linn, Michael G. | 6.80% | 15,000,000 |
| Luo Patrick (Cheng) | 6.80% | 15,000,000 |
| Roberts, Jr., Thomas G. | 6.80% | 15,000,000 |
| Saito Edric C. | 6.80% | 15,000,000 |
| Short Daniel S. | 6.80% | 15,000,000 |
| Spokes, Andrew J. M. | 6.80% | 15,000,000 |
| Warren, John R. | 6.80% | 15,000,000 |
| Wehrly, Mark C. | 6.80% | 15,000,000 |
Source
Related
- Savara, Inc.
- Farallon Capital Management, L.L.C.
- Savara, Inc. shareholders
- Form 4 · Parker Braden C. · Sep 25, 2026
- Form 4 · Lutz Robert Matthew · Jul 24, 2026
- Form 4 · Lowrance David L · Jun 22, 2026
- Schedule 13G/A · TCG Crossover GP I, LLC · Feb 17, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Feb 17, 2026